X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - PHARMABIZ.COM - A la Une - 11/Oct 15:50

Science 37 completes third US FDA inspection; concludes with no action indicated

Science 37, a leader in enhancing patient access to clinical trials, announced the successful completion of its third US FDA inspection and

Articles similaires

Sorry! Image not available at this time

Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule

wn.com - 21/Oct 13:50

This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and pharmacokinetics of...

Sorry! Image not available at this time

MIRA Pharmaceuticals Initiates Multiple Ascending Dose (MAD) Phase 1 Study of Oral Ketamir-2 and Selects Chemotherapy-Induced Neuropathic Pain as Lead Phase 2a Indication

wn.com - 24/Oct 14:04

Advancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track...

Sorry! Image not available at this time

Altimetrik Completes Acquisition of SLK Software, Uniting Strengths to Unlock Value through AI-First and Digital Enablement

financialpost.com - 24/Oct 17:02

DETROIT & BENGALURU, India — Altimetrik today announced the successful completion of its acquisition of SLK Software, marking a major...

Sorry! Image not available at this time

Altimetrik Completes Acquisition of SLK Software, Uniting Strengths to Unlock Value through AI-First and Digital Enablement

mangaloremirror.com - 25/Oct 08:15

Business Wire India   Altimetrik today announced the successful completion of its acquisition of SLK Software, marking a major milestone in the...

Sorry! Image not available at this time

selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease

wn.com - 21/Oct 09:01

Disease modifying mechanism of action: short treatment course results in significant and durable clinical response in psoriasis patients si-544 is the...

Sorry! Image not available at this time

Giles introduces AI agent to accelerate healthcare and life science research

news.medical.net - 21/Oct 10:53

giles AI, a company making advanced research tools accessible to all and simplifying how scientists work with data, has announced the commercial...

Sorry! Image not available at this time

Moniepoint announces successful completion of $200m Series C round to power financial inclusion

worldstagenews.com - 21/Oct 09:43

WorldStage– Moniepoint Inc., Africa’s all-in-one financial platform for businesses and their customers have  announced that it raised over US$200...

Sorry! Image not available at this time

US FDA clears SINTX Technologies' SINAPTIC Foot & Ankle implant system

pharmabiz.com - 22/Oct 12:12

SINTX Technologies, Inc., a leader in advanced ceramics specializing in biomedical applications of silicon nitride (Si3N4), announced US Food and Drug...

Sorry! Image not available at this time

Manufacturing news briefs — stories you might have missed

aumanufacturing.com.au - 23:57

Biochip meets performance and clinical requirements, says Archer  Semiconductor developer Archer Materials this week announced successful results...

Sorry! Image not available at this time

Heidelberg Pharma’s Lead ADC Candidate HDP-101 Granted Fast Track Designation by US FDA for the Treatment of Multiple Myeloma

wn.com - 23/Oct 10:39

· Recognizes the potential of HDP-101 to address a serious or life-threatening condition with high unmet medical needs · Enables...

Les derniers communiqués